Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
More News
(White Plains/Peekskill/Bronx, NY), June X, 2026 — Statewide Abstract, a BCW member, has announced the acquisition of RG Title Agency, a respected and long-standing title insurance agency based in Peekskill and serving the New York real estate community since 1956. The acquisition marks a significant milestone in Statewide Abstract’s continued growth strategy and further strengthens […]
The Business Council of Westchester (BCW) has joined more than 400 state and local chambers of commerce from all 50 states in supporting the BUILD America 250 Act (H.R. 8870), a bipartisan infrastructure proposal aimed at strengthening America’s transportation network and long-term economic competitiveness. Led by the U.S. Chamber of Commerce, the coalition recently submitted […]
Collaboration with Iona University’s Hynes Institute, a BCW member, will expand local business’ access to small business resources and expertise, anchoring the downtown with a forthcoming innovation hub NEW ROCHELLE, NEW YORK (June 29, 2026) – The City of New Rochelle today announced a new partnership with Iona University’s Hynes Institute for Entrepreneurship & Innovation, a […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.